Robert Doebele, MD, PhD
Associate Clinical Professor, Medicine-Medical Oncology

Associate Professor of Medicine
ORIEN Scientific Officer
Molecular Tumor Board, Co-Director
Director, Thoracic Oncology Research Initiative
Featured Provider Photo

Gender: Male
Languages: English
Department, Section/Division: Medicine-Medical Oncology

Practice Locations

Lung Cancer Clinic - Anschutz
1665 Aurora Ct
Anschutz Cancer Pavilion
Aurora, CO 80045
More providers at this location

UCH - Cancer Center
1665 Aurora Ct
Aurora, CO 80045
More providers at this location

University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
More providers at this location

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

  • Internal Medicine - Medical Oncology, Board Certification (2007)
Conditions & Treatments
  • Cancers
  • Lung Cancer
Clinical Interest for Patients
I am interested in advancing precision medicine for lung cancer which includes identifying new gene targets. It also includes understanding mechanisms of resistance to targeted therapies. When I am not seeing patients in the clinic I run a laboratory that is developing new models for cancer research and studying mechanisms of drug resistance to targeted therapies.

Care Philosophy
Providing the most up-to-date care for lung care using precision medicine and immunotherapy approaches when appropriate.

Personal Interests
Skiing, hiking, camping, and travel.

Public Speaking
I lecture across the US and the world on oncogene-targeted therapies and drug resistance.

Information for Referring Providers

Clinical Interests for Referring Providers
Precision medicine for lung cancer and other malignancies with expertise in oncogene-driven lung cancer harboring ALK, ROS1, EGFR, HER2, BRAF, RET, MET and other oncogenes. Thoracic Malignancies (Non-small Cell Lung Cancer, Small Cell Lung Cancer, Malignant Mesothelioma, Malignant Thymoma/Thymic Carcinoma)

Research Interest for Referring Providers
My research interests are primary focused on oncogene-driven cancer (ALK, ROS1, RET, NTRK1/2/3, MET, EGFR) and drug-resistance to targeted therapies. My laboratory derives new cancer models by making human cell lines and interrogating these models to understand how to better treat cancers with combination targeted therapies.
Clinic Phone: (720) 848-0300

CV RCDoebele current CV SOM 2018.06.24.docx